Bank of New York Mellon’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-33,526
| Closed | -$773K | – | 4400 |
|
|
2020
Q4 | $773K | Sell |
33,526
-95,826
| -74% | -$2.21M | ﹤0.01% | 3394 |
|
|
2020
Q3 | $1.32M | Sell |
129,352
-68,116
| -34% | -$694K | ﹤0.01% | 2947 |
|
|
2020
Q2 | $2.94M | Sell |
197,468
-27,686
| -12% | -$412K | ﹤0.01% | 2469 |
|
|
2020
Q1 | $2.75M | Buy |
225,154
+11,664
| +5% | +$142K | ﹤0.01% | 2379 |
|
|
2019
Q4 | $3.38M | Buy |
213,490
+3,419
| +2% | +$54.1K | ﹤0.01% | 2534 |
|
|
2019
Q3 | $2.58M | Buy |
+210,071
| New | +$2.58M | ﹤0.01% | 2616 |
|